In conclusion, ceramide-CD300f interactions inhibit LPS-induced skin edema and neutrophil accumulation, implicating CD300f as a negative regulator of TLR4 signaling in myeloid cells in vivo that is involved in a variety of TLR4-dependent non-infectious inflammatory diseases as well as infectious diseases. The gene discussed is CD300LF; the disease is infectious disease.